{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:41:35Z","timestamp":1784241695735,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013057","name":"Heffter Research Institute","doi-asserted-by":"publisher","award":["1\u2013190420"],"award-info":[{"award-number":["1\u2013190420"]}],"id":[{"id":"10.13039\/100013057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014269","name":"Philippe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["01EW1908"],"award-info":[{"award-number":["01EW1908"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01MH121766"],"award-info":[{"award-number":["1U01MH121766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01MH108590"],"award-info":[{"award-number":["5R01MH108590"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01MH112189"],"award-info":[{"award-number":["5R01MH112189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopsych.2022.10.021","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:59:17Z","timestamp":1670410757000},"page":"1061-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans"],"prefix":"10.1016","volume":"93","author":[{"given":"Flora","family":"Moujaes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-7672","authenticated-orcid":false,"given":"Katrin H.","family":"Preller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Lisa","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Anticevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2022.10.021_bib1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tips.2017.08.003","article-title":"Psychedelic drugs in biomedicine","volume":"38","author":"Kyzar","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2022.10.021_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2022.10.021_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fpsyt.2019.00943","article-title":"Therapeutic use of LSD in psychiatry: A systematic review of randomized-controlled clinical trials","volume":"10","author":"Fuentes","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: Neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2022.10.021_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2022.10.021_bib15","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050324516683325","article-title":"Constructing drug effects: A history of set and setting","volume":"3","author":"Hartogsohn","year":"2017","journal-title":"Drug Sci Policy Law"},{"key":"10.1016\/j.biopsych.2022.10.021_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenb\u00e6k","year":"2021","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90343-y","article-title":"Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis","volume":"11","author":"Vizeli","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.10.021_bib22","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.neuron.2022.07.005","article-title":"Functional neuroimaging in psychiatry and the case for failing better","volume":"110","author":"Nour","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2022.10.021_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104689","article-title":"Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses","volume":"138","author":"McCulloch","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2022.10.021_bib24","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.biopsych.2022.10.021_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.021_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.10.021_bib27","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.10.021_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.021_bib29","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: Regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41386-020-00823-4","article-title":"Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin","volume":"46","author":"Madsen","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","volume":"36","author":"McCulloch","year":"2022","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib32","article-title":"Decreased brain modularity after psilocybin therapy for depression","author":"Daws","year":"2021","journal-title":"Research Square"},{"key":"10.1016\/j.biopsych.2022.10.021_bib33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1017\/S0033291715002901","article-title":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","volume":"46","author":"Carhart-Harris","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2022.10.021_bib35","first-page":"461","article-title":"Preliminary report on the effects of a low dose of LSD on resting-state amygdala functional connectivity","volume":"5","author":"Bershad","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.biopsych.2022.10.021_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.biopsych.2022.10.021_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2022.10.021_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \u201cAfter-Glow\u201d in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/0269881120909409","article-title":"Subacute effects of the psychedelic ayahuasca on the salience and default mode networks","volume":"34","author":"Pasquini","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: Contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2022.10.021_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/brain\/awab406","article-title":"Models of psychedelic drug action: Modulation of cortical-subcortical circuits","volume":"145","author":"Doss","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2022.10.021_bib43","first-page":"777","article-title":"Biophysical modeling of large-scale brain dynamics and applications for computational psychiatry","volume":"3","author":"Murray","year":"2018","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.biopsych.2022.10.021_bib44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bies.201100185","article-title":"Beyond the connectome: How neuromodulators shape neural circuits","volume":"34","author":"Bargmann","year":"2012","journal-title":"BioEssays"},{"key":"10.1016\/j.biopsych.2022.10.021_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2012.09.010","article-title":"Neuromodulation of neuronal circuits: Back to the future","volume":"76","author":"Marder","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2022.10.021_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.conb.2014.06.004","article-title":"Neuromodulation by acetylcholine: Examples from schizophrenia and depression","volume":"29","author":"Higley","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuron.2012.09.012","article-title":"Neuromodulation of brain states","volume":"76","author":"Lee","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2022.10.021_bib48","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.cub.2018.07.083","article-title":"Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD","volume":"28","author":"Deco","year":"2018","journal-title":"Curr Biol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"Presto-Tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2022.10.021_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(93)90205-Y","article-title":"Excitatory and inhibitory effects of 5-hydroxytryptamine on the firing rate of medial vestibular nucleus neurons in the rat","volume":"154","author":"Licata","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2022.10.021_bib52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0306-4522(93)90541-M","article-title":"Serotonin-evoked modifications of the neuronal firing rate in the superior vestibular nucleus: A microiontophoretic study in the rat","volume":"52","author":"Licata","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2022.10.021_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(91)91440-C","article-title":"Changes in motor performance and rubral single unit activity in cats after microinjections of serotonin into the red nucleus area","volume":"567","author":"Schmied","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2022.10.021_bib54","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00213-022-06117-5","article-title":"Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD","volume":"239","author":"Lawn","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroimage.2019.04.007","article-title":"Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA","volume":"195","author":"Dipasquale","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.021_bib56","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41593-018-0195-0","article-title":"Hierarchy of transcriptomic specialization across human cortex captured by structural neuroimaging topography","volume":"21","author":"Burt","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib57","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib58","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","article-title":"Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience","volume":"26","author":"Pokorny","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib60","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41593-017-0011-2","article-title":"A\u00a0multiregional proteomic survey of the postnatal human brain","volume":"20","author":"Carlyle","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib61","first-page":"120","article-title":"A\u00a0high-resolution in\u00a0vivo atlas of the human brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0022-3565(25)20792-3","article-title":"LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex","volume":"278","author":"Marek","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2022.10.021_bib63","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1046\/j.1460-9568.1999.00726.x","article-title":"LSD and DOB: Interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex","volume":"11","author":"Arvanov","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib64","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1073\/pnas.1524187113","article-title":"Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing","volume":"113","author":"Preller","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2022.10.021_bib65","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/cercor\/bhab202","article-title":"Psilocybin induces aberrant prediction error processing of tactile mismatch responses-A simultaneous EEG-FMRI study","volume":"32","author":"Duerler","year":"2021","journal-title":"Cereb Cortex"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2022.10.021_bib67","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/schbul\/sbt179","article-title":"Bipolar and schizophrenia network for intermediate phenotypes: Outcomes across the psychosis continuum","volume":"40","author":"Tamminga","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2022.10.021_bib68","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamapsychiatry.2018.2165","article-title":"Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: A multimodal, multisite machine learning analysis","volume":"75","author":"Koutsouleris","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.dcn.2018.03.001","article-title":"The adolescent brain cognitive development (ABCD) study: Imaging acquisition across 21 sites","volume":"32","author":"Casey","year":"2018","journal-title":"Dev Cogn Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroimage.2013.05.041","article-title":"The WU-Minn human connectome project: An overview","volume":"80","author":"Van Essen","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.021_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2020.04.010","article-title":"North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description","volume":"243","author":"Addington","year":"2022","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2022.10.021_bib73","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.neuroimage.2015.03.056","article-title":"The Philadelphia Neurodevelopmental Cohort: A publicly available resource for the study of normal and abnormal brain development in youth","volume":"124","author":"Satterthwaite","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.021_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib75","first-page":"478","article-title":"Canonical correlation analysis for identifying biotypes of depression","volume":"5","author":"Mihalik","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.biopsych.2022.10.021_bib76","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1038\/s41467-018-05317-y","article-title":"Linked dimensions of psychopathology and connectivity in functional brain networks","volume":"9","author":"Xia","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2022.10.021_bib77","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1073\/pnas.1900801116","article-title":"Childhood trauma history is linked to abnormal brain connectivity in major depression","volume":"116","author":"Yu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2022.10.021_bib78","article-title":"Mapping brain-behavior space relationships along the psychosis spectrum [published correction appears in Elife 2022;11:e79129]","volume":"10","author":"Ji","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.biopsych.2022.10.021_bib79","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nn.4125","article-title":"A\u00a0positive-negative mode of population covariation links brain connectivity, demographics and behavior","volume":"18","author":"Smith","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tics.2011.11.015","article-title":"Cognition in schizophrenia: Core psychological and neural mechanisms","volume":"16","author":"Barch","year":"2012","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopsych.2019.08.031","article-title":"Neurobiological divergence of the positive and negative schizophrenia subtypes identified on a new factor structure of psychopathology using non-negative factorization: An international machine learning study","volume":"87","author":"Chen","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/h0040957","article-title":"Construct validity in psychological tests","volume":"52","author":"Cronbach","year":"1955","journal-title":"Psychol Bull"},{"key":"10.1016\/j.biopsych.2022.10.021_bib83","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4088\/JCP.10r06332gre","article-title":"Should we expect \u201cneural signatures\u201d for DSM diagnoses?","volume":"72","author":"Gillihan","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2013.04.027","article-title":"Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5","volume":"150","author":"Barch","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2022.10.021_bib85","article-title":"Ketamine induces two individually distinct whole-brain functional connectivity signatures","author":"Moujaes","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2022.10.021_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101796","article-title":"Evaluating the evidence for biotypes of depression: Methodological replication and extension of","volume":"22","author":"Dinga","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.biopsych.2022.10.021_bib87","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-022-04492-9","article-title":"Reproducible brain-wide association studies require thousands of individuals","volume":"603","author":"Marek","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2022.10.021_bib88","article-title":"On stability of canonical correlation analysis and partial least squares with application to brain-behavior associations","author":"Helmer","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2022.10.021_bib89","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: A randomized, double-blind, placebo-controlled Phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib91","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib92","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib93","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neubiorev.2020.09.035","article-title":"Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review","volume":"119","author":"Ona","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2022.10.021_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13143","article-title":"Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study","volume":"27","author":"de Wit","year":"2022","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/02698811211050556","article-title":"Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study","volume":"36","author":"Marschall","year":"2022","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib97","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.biopsych.2022.10.021_bib98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: A double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib99","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2022.10.021_bib100","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00213-021-05857-0","article-title":"Effects of psilocybin microdosing on awe and aesthetic experiences: A preregistered field and lab-based study","volume":"239","author":"van Elk","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib101","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib102","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269881120940937","article-title":"A\u00a0low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","volume":"35","author":"Ramaekers","year":"2021","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib103","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib104","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-021-05991-9","article-title":"Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults","volume":"239","author":"Murray","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib106","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","article-title":"Tripping on nothing: Placebo psychedelics and contextual factors","volume":"237","author":"Olson","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib107","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2022.10.021_bib108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2022.10.021_bib109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69320","article-title":"Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","volume":"10","author":"Burt","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.biopsych.2022.10.021_bib111","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.biopsych.2022.10.021_bib112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"L\u00f3pez-Figueroa","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.021_bib113","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.021_bib114","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2022.10.021_bib115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322018054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322018054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:38Z","timestamp":1762099778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322322018054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":115,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0006322322018054"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.021","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}